{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-012718","form_type":"8-K","ticker":"MTNB","cik":"0001582554","company_name":"Matinas BioPharma Holdings, Inc.","filed_at":"2023-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.510237+00:00","generated_at":"2026-06-17T00:45:22.664288+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Matinas BioPharma: compassionate use patient complete resolution of rare fungal infection with MAT2203; Phase 3 planned","bullets":["Patient treated with MAT2203 achieved complete clinical resolution of R. mucilaginosa infection after 6 months and regained use of foot.","MAT2203 was well-tolerated with no renal adverse effects; patient's renal function improved and remained at baseline.","Prior IV-amphotericin B was discontinued due to electrolyte abnormalities and toxicities; MAT2203 allowed outpatient monitoring.","Company in final stages of planning Phase 3 program for MAT2203 with FDA."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-012718","json":"https://secwatch.observer/filing/0001493152-23-012718.json","markdown":"https://secwatch.observer/filing/0001493152-23-012718.md","text":"https://secwatch.observer/filing/0001493152-23-012718.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582554/000149315223012718/0001493152-23-012718-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582554/000149315223012718/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T00:45:22.664288+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}